| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1140e13d2e1ef703992f611457fb1b7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47778f34cc91288d715a8a6ce0be019f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5e02c4c163b47b667c47d3f6e26eef |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate |
2000-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b60863e1a000b173ad2849e5d794d624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6e7a0dadf1b4c2d03c596fcef7f46b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70483891b27c673eebbd5779acf5e360 |
| publicationDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0051616-A1 |
| titleOfInvention |
Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives |
| abstract |
The present invention relates to novel methods of increasing bone volume comprising the administration of a non-naturally-occurring FP selective agonist and a non-naturally-occurring EP1 selective agonist to a subject in need of such treatment. This invention further relates to a method of treating or preventing bone disorders comprising the administration of a non-naturally-occurring FP selective agonist and a non-naturally-occurring EP1 selective agonist to a subject in need of such treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009133863-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0051585-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0051585-A2 |
| priorityDate |
1999-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |